| Product NDC: | 0517-4901 |
| Proprietary Name: | Dexamethasone Sodium Phosphates |
| Non Proprietary Name: | Dexamethasone Phosphate |
| Active Ingredient(s): | 4 mg/mL & nbsp; Dexamethasone Phosphate |
| Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0517-4901 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087440 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19900930 |
| Package NDC: | 0517-4901-25 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4901-25) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0517-4901-25 |
| Proprietary Name | Dexamethasone Sodium Phosphates |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4901-25) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0517-4901 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dexamethasone Phosphate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
| Start Marketing Date | 19900930 |
| Marketing Category Name | ANDA |
| Labeler Name | American Regent, Inc. |
| Substance Name | DEXAMETHASONE PHOSPHATE |
| Strength Number | 4 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |